Approval · Notice of Compliance 1437 · 2000
RAMACE: Notice of Compliance 1437
Issued October 10, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1437
- Date
- October 10, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAMACE | 02051788 | — |
| RAMACE | 02051796 | — |
| RAMACE | 02051818 | — |
| RAMACE | 02242874 | — |